Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-8235
J Med Chem 2001 Oct 25;4422:3582-91. doi: 10.1021/jm010903i.
Show Gene links Show Anatomy links

Alpha-amino acid phenolic ester derivatives: novel water-soluble general anesthetic agents which allosterically modulate GABA(A) receptors.

Anderson A , Belelli D , Bennett DJ , Buchanan KI , Casula A , Cooke A , Feilden H , Gemmell DK , Hamilton NM , Hutchinson EJ , Lambert JJ , Maidment MS , McGuire R , McPhail P , Miller S , Muntoni A , Peters JA , Sansbury FH , Stevenson D , Sundaram H .


???displayArticle.abstract???
In the search for a novel water-soluble general anesthetic agent the activity of an alpha-amino acid phenolic ester lead, identified from patent literature, was markedly improved. In addition to improving in vivo activity in mice, good in vitro activity at GABA(A) receptors was also conferred. Within the series of compounds good enantioselectivity for both in vitro and in vivo activity was found, supporting a protein-mediated mechanism of action for anesthesia involving allosteric modulation of GABA(A) receptors. alpha-Amino acid phenolic ester 19, as the hydrobromide salt Org 25435, was selected for clinical evaluation since it retained the best overall anesthetic profile coupled with improved stability and water solubility. In the clinic it proved to be an effective intravenous anesthetic in man with rapid onset of and recovery from anesthesia at doses of 3 and 4 mg/kg.

???displayArticle.pubmedLink??? 11606122
???displayArticle.link??? J Med Chem